This is supported by the fact that activating STAT5B mutations and particularly STAT5BN642H also occur in T cell large granular lymphocytic leukemia, T cell prolymphocytic leukemia, and various γδ T cell–derived leukemias/lymphomas (18). This evidence concerns the gene STAT5B and lymphoma.